Precision Cancer Imaging Market is expected to grow at a CAGR of 12% by 2032 | FMI Study

The Precision Cancer Imaging Market is expected to grow at a CAGR of 12% during the forecast period, from US$ 67.8 billion in 2022 to US$ 210.58 billion by 2032. Precision cancer imaging system sales are expected to increase as patients become more aware of the molecular basis of cancer and express a preference for …

United States is expected to account for more than 40% of the Biosimulation Market by 2032 | FMI

The global Biosimulation Market was estimated to be worth roughly US$ 2.6 billion in 2021; however, a CAGR of 21.5% is predicted for the following ten years, meaning that by the end of 2032, the market is likely to have grown to be worth US$ 20.9 billion. The need for biosimulation will be driven by …

Age Related Vision Dysfunction Market in North America is expected to grow at a CAGR of 3.6% in the assessment period 2023 to 2033 | FMI Analysis

A recently published study by FMI expects the global Age-Related Vision Dysfunction Market to augment at a 3.7% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 130 Billion is expected for the market. The rising incidence of visual impairment and blindness is a primary driver of …

Idiopathic Pulmonary Fibrosis Management Market is expected to register a CAGR of 1.5% in the forecast period 2023 to 2033 | FMI

During the forecast period 2023 to 2033, the Idiopathic Pulmonary Fibrosis Management Market is expected to grow at a value of 1.5% CAGR, according to Future Market Insights. By the year 2033, the global market for Idiopathic pulmonary fibrosis management is expected to rise up to a market valuation of US$ 3649.90 Million. The growth …

Multiplex Molecular Diagnostics Market to reach the valuation of US$ 39.25 Billion by 2032

[Report of 250 Pages] The multiplex molecular diagnostics market is projected to grow at a CAGR of 5.4% over the course of the forecast period, from an estimated value of US$ 23.2 billion in 2022 to US$ 39.25 billion by 2032.  Multiplex Molecular Diagnostics Market: Overview Highly multiplexed molecular diagnostics are powerful tools for patient care, epidemiologic …

Neuro Monitoring System Positioning and Growing Market size is anticipated to be valued at US$ 9.4 Billion in 2032

[Report of 250 Pages] In 2032, the market for neuro monitoring systems is expected to be worth US$9.4 billion. The market for neuro monitoring systems is expected to grow in the coming years due to the rising number of complicated and critical surgeries performed around the world. The demand for neuro monitoring systems is anticipated to reach …

Malignant Pleural Effusion Market value of US$ 4.5 Billion in 2023

The global malignant pleural effusion market is expected to garner a market value of US$ 4.5 Billion in 2023 and is expected to accumulate a market value of US$ 8.06 Billion by registering a CAGR of 6% in the forecast period 2023-2033. The increasing incidence of pleural effusion disease and rising awareness of advancement in pleural effusions …

Buttock Augmentation Market is expected to increase at a CAGR of around 27.4% from 2022 to 2032

According to Future Market Insights’ newly released Buttock Augmentation Market analysis report, global sales of the Buttock Augmentation Market in 2021 were held at US$ 1.9 Billion. The market is expected to reach a valuation of US$ 26.9 Billion by 2032, with a CAGR of 27.4% between 2022 and 2032. Buttock Implants is expected to be the highest revenue-generating segment, with a CAGR of …

Common Warts Market by registering a CAGR of 3.6% from 2023 to 2033

A recently published study by FMI expects the global common warts market to augment at a 3.6% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 1,100 Million is expected for the market. The increase in pharmaceutical R&D activity for efficient and focused treatment of common warts is propelling …

Bovine Lactoferrin Market to reach US$ 3.3 Billion by 2033; Infant Formula accounts for 40% of Application | FMI Report

The global bovine lactoferrin market is predicted to expand at a CAGR of 15.8% between 2023 and 2033, from US$ 772.39 Million to US$ 3,349.05 Million. The increasing consumer awareness of health and diet and the growing incidences of skin-related medical issues are expected to stimulate demand. Lactoferrin is thought to have antiviral, antimicrobial, antiparasitic, …